ABSTRACT COVID-19 vaccines emerging from different platforms differ in efficacy, duration
of protection, and side effects. To maximize the benefits of vaccination, we explored the …

The emergence and rapid global spread of the new Delta and, more recently, Omicron
variants of SARS-CoV-2 pose a daunting public health emergency. Being an RNA virus, the …

The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

A massive COVID-19 vaccination campaign is underway worldwide. Epidemiological data
from studies indicate excellent efficacy and safety profile for COVID-19 vaccines. However …

Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
highlights the importance of determining the breadth and durability of humoral immunity to …

A key goal to controlling coronavirus disease 2019 (COVID-19) is developing an effective
vaccine. Development of a vaccine requires knowledge of what constitutes a protective …

Abstract Coronavirus disease 2019 (COVID-19) has caused millions of deaths, and serious
consequences to public health, economies and societies. Rapid responses in vaccine …

An unprecedented outbreak of pneumonia caused by a novel coronavirus (CoV),
subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City …

The teams of researchers scrambling to develop a coronavirus disease 2019 (COVID-19)
vaccine clearly face some big challenges, both scientific and logistical. One of the most …